Encompass Health Corp (EHC) to Post FY2020 Earnings of $3.93 Per Share, SunTrust Banks Forecasts

Encompass Health Corp (AMEX:EHC) – Investment analysts at SunTrust Banks lifted their FY2020 EPS estimates for Encompass Health in a research report issued to clients and investors on Monday, April 29th. SunTrust Banks analyst D. Macdonald now anticipates that the company will post earnings per share of $3.93 for the year, up from their prior forecast of $3.92.

Separately, Zacks Investment Research lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday, January 9th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $79.00.

Encompass Health has a twelve month low of $40.86 and a twelve month high of $59.29.

Encompass Health (AMEX:EHC) last issued its quarterly earnings data on Thursday, April 25th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.15. The company had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same quarter in the previous year, the business earned $0.93 earnings per share. The company’s revenue was up 7.5% on a year-over-year basis.

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a dividend of $0.27 per share. The ex-dividend date was Friday, March 29th. This represents a $1.08 dividend on an annualized basis and a dividend yield of ∞.

In related news, Director Leo I. Higdon, Jr. acquired 1,000 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The shares were acquired at an average cost of $58.84 per share, for a total transaction of $58,840.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.60% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Encompass Health by 2.2% in the 3rd quarter. Vanguard Group Inc. now owns 9,285,576 shares of the company’s stock valued at $723,811,000 after buying an additional 200,890 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Encompass Health by 1.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,433,372 shares of the company’s stock valued at $111,731,000 after buying an additional 21,766 shares during the last quarter. Morgan Stanley increased its stake in Encompass Health by 25.8% in the 3rd quarter. Morgan Stanley now owns 638,008 shares of the company’s stock valued at $49,731,000 after buying an additional 130,728 shares during the last quarter. AQR Capital Management LLC increased its stake in Encompass Health by 177.2% in the 3rd quarter. AQR Capital Management LLC now owns 70,264 shares of the company’s stock valued at $5,477,000 after buying an additional 44,915 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in Encompass Health by 13.6% in the 3rd quarter. Nordea Investment Management AB now owns 57,325 shares of the company’s stock valued at $4,468,000 after buying an additional 6,856 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Read More: What is the LIBOR?

Earnings History and Estimates for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit